Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Disc Medicine Inc (IRON)

Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,738,742
  • Shares Outstanding, K 38,160
  • Annual Sales, $ 0 K
  • Annual Income, $ -212,180 K
  • EBIT $ -236 M
  • EBITDA $ -244 M
  • 60-Month Beta 0.91
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.56

Options Overview Details

View History
  • Implied Volatility 51.94% (-3.36%)
  • Historical Volatility 40.50%
  • IV Percentile 18%
  • IV Rank 12.21%
  • IV High 131.40% on 01/20/26
  • IV Low 40.89% on 09/12/25
  • Expected Move (DTE 25) 6.84 (9.53%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6,010
  • Volume Avg (30-Day) 376
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 4,966
  • Open Int (30-Day) 4,561
  • Expected Range 64.93 to 78.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-1.55
  • Number of Estimates 7
  • High Estimate $-1.48
  • Low Estimate $-1.59
  • Prior Year $-1.02
  • Growth Rate Est. (year over year) -51.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
57.72 +24.35%
on 03/19/26
71.85 -0.10%
on 04/17/26
+11.79 (+19.66%)
since 03/17/26
3-Month
40.00 +79.42%
on 02/13/26
83.93 -14.49%
on 02/05/26
+0.84 (+1.18%)
since 01/16/26
52-Week
40.00 +79.42%
on 02/13/26
99.50 -27.87%
on 12/08/25
+29.60 (+70.21%)
since 04/17/25

Most Recent Stories

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON

NEW YORK , April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ: IRON). Such investors are advised...

IRON : 71.77 (+3.34%)
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK , April 14, 2026 /PRNewswire/ -- 

IRON : 71.77 (+3.34%)
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK , April 9, 2026 /PRNewswire/ --

IRON : 71.77 (+3.34%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON

NEW YORK , April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ: IRON). Such investors are advised...

IRON : 71.77 (+3.34%)
Investors in Disc Medicine, Inc. (IRON) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. (NASDAQ: IRON) ("Disc Medicine, Inc.") concerning...

IRON : 71.77 (+3.34%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON

NEW YORK , April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ: IRON).  Such investors are advised...

IRON : 71.77 (+3.34%)
IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine

Investigation examines gap between reported figures and GAAP results at Disc Medicine ahead of its 21.9% stock collapse

IRON : 71.77 (+3.34%)
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK , March 30, 2026 /PRNewswire/ --

IRON : 71.77 (+3.34%)
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Disc Medicine, Inc. (IRON)

New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. ("Disc Medicine, Inc.") (NASDAQ: IRON) concerning...

IRON : 71.77 (+3.34%)
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria

Last participant has been randomized and dosed in the Phase 3 APOLLO study of bitopertin in erythropoietic protoporphyria (EPP) The study size was expanded to 183 participants due to patient and physician...

IRON : 71.77 (+3.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Disc Medicine Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases. Disc Medicine Inc., formerly known as Gemini Therapeutics Inc., is based in WAYLAND, Mass.

See More

Key Turning Points

3rd Resistance Point 75.83
2nd Resistance Point 73.84
1st Resistance Point 72.80
Last Price 71.77
1st Support Level 69.78
2nd Support Level 67.79
3rd Support Level 66.75

See More

52-Week High 99.50
Fibonacci 61.8% 76.77
Last Price 71.77
Fibonacci 50% 69.75
Fibonacci 38.2% 62.73
52-Week Low 40.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.